DHCR7 mutations and genotype-phenotype correlation in 37 Polish patients with Smith-Lemli-Opitz syndrome

被引:24
作者
Ciara, E
Nowaczyk, MJM
Witsch-Baumgartner, M
Malunowicz, E
Popowska, E
Jezela-Stanek, A
Piotrowicz, M
Waye, JS
Utermann, G
Krajewska-Walasek, M
机构
[1] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland
[2] Inst Med Biol & Human Genet, Dept Med Genet, Innsbruck, Austria
[3] Childrens Mem Hlth Inst, Dept Lab Diagnost, PL-04730 Warsaw, Poland
[4] Polish Mothers Hosp Res Inst, Dept Med Genet, Lodz, Poland
[5] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
关键词
DHCR7; genotype-phenotype correlation; Smith-Lemli-Opitz syndrome;
D O I
10.1111/j.1399-0004.2004.00350.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder of cholesterol biosynthesis caused by mutations in the DHCR7 gene. Thirty-seven ethnic Polish patients with SLOS underwent mutation analysis. The mutation frequencies in Polish patients were significantly different from those observed in Western European populations. Two mutations, W151X (22/68 alleles, 32%) and V326L (19/68 alleles, 28%), accounted for 60% of all observed in our cohort. Two missense mutations L68P and L360P have not been reported previously. In total, we report 15 DHCR7 mutations identified in Polish patients. By comparing clinical severity scores and the biochemical and molecular data, a genotype-phenotype correlation was attempted. In compound heterozygotes with one null mutation, the phenotype severity depends on the localization and type of the second mutation: mild phenotypes are correlated with mutations affecting the putative transmembrane domains TM1-TM6 or CT regions and severe phenotypes with mutations localized in TM7 and 4L region. The phenotypic differences of patients with the same genotype suggest that severity of the disease may be affected by other factors.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 30 条
[1]  
Bzdúch V, 2000, AM J MED GENET, V90, P260, DOI 10.1002/(SICI)1096-8628(20000131)90:3<260::AID-AJMG17>3.0.CO
[2]  
2-R
[3]   Smith-Lemli-Opitz syndrome:: evidence of T93M as a common mutation of Δ7-sterol reductase in Italy and report of three novel mutations [J].
De Brasi, D ;
Esposito, T ;
Rossi, M ;
Parenti, G ;
Sperandeo, MP ;
Zuppaldi, A ;
Bardaro, T ;
Ambruzzi, MA ;
Zelante, L ;
Ciccodicola, A ;
Sebastio, G ;
D'Urso, M ;
Andria, G .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (08) :937-940
[4]   Mutations in the Δ7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome [J].
Fitzky, BU ;
Witsch-Baumgartner, M ;
Erdel, M ;
Lee, JN ;
Paik, YK ;
Glossmann, H ;
Utermann, G ;
Moebius, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8181-8186
[5]  
GRUBER M, IN PRESS J MED GENET
[6]   DEFECTIVE CHOLESTEROL-BIOSYNTHESIS IN SMITH-LEMLI-OPTIZ SYNDROME [J].
IRONS, M ;
ELIAS, ER ;
SALEN, G ;
TINT, GS ;
BATTA, AK .
LANCET, 1993, 341 (8857) :1414-1414
[7]  
Jira PE, 2001, ANN HUM GENET, V65, P229, DOI 10.1017/S0003480001008600
[8]   The Smith-Lemli-Opitz syndrome [J].
Kelley, RI ;
Hennekam, RCM .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (05) :321-335
[9]   DIAGNOSIS OF SMITH-LEMLI-OPITZ SYNDROME BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY OF 7-DEHYDROCHOLESTEROL IN PLASMA, AMNIOTIC-FLUID AND CULTURED SKIN FIBROBLASTS [J].
KELLEY, RI .
CLINICA CHIMICA ACTA, 1995, 236 (01) :45-58
[10]   Smith-Lemli-Opitz syndrome:: Molecular-genetic analysis of ten families [J].
Kozák, L ;
Francová, H ;
Hrabincová, E ;
Procházková, D ;
Jüttnerová, V ;
Bzdúch, V ;
Simek, P .
JOURNAL OF INHERITED METABOLIC DISEASE, 2000, 23 (04) :409-412